|
|
|
Volumn 242, Issue 740, 1997, Pages 43-48
|
|
New therapies for the haemoglobinopathies
a
a
NONE
|
|
Author keywords
Butyrates; Fetal haemoglobin; Haemoglobin F; Haemoglobinopathies; Hydroxyurea
|
|
Indexed keywords
ALPHA GLOBIN;
AZACITIDINE;
BUTYRIC ACID DERIVATIVE;
ERYTHROPOIETIN;
HEMOGLOBIN F;
HEMOGLOBIN GAMMA CHAIN;
HEMOGLOBIN S;
HYDROXYUREA;
RIBONUCLEOTIDE REDUCTASE;
ANTISICKLING AGENT;
BUTYRIC ACID;
BETA THALASSEMIA;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG TOLERANCE;
ERYTHROID PRECURSOR CELL;
ERYTHROPOIESIS;
GENE ACTIVATION;
HEMOGLOBIN SYNTHESIS;
HEMOGLOBINOPATHY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
MUTAGENICITY;
PRIORITY JOURNAL;
PROMOTER REGION;
SICKLE CELL ANEMIA;
THROMBOCYTOPENIA;
DRUG COMBINATION;
REVIEW;
THALASSEMIA;
ANEMIA, SICKLE CELL;
ANTISICKLING AGENTS;
BUTYRIC ACID;
BUTYRIC ACIDS;
DRUG THERAPY, COMBINATION;
ERYTHROPOIETIN;
HEMOGLOBINOPATHIES;
HUMANS;
HYDROXYUREA;
THALASSEMIA;
|
|
EID: 0030624054
PISSN: 09557873
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (2)
|
